本页面由Tiger Trade Technology Pte. Ltd.提供服务

Atea Pharmaceuticals, Inc.

5.76
+0.11001.95%
盘后5.760.00000.00%16:48 EDT
成交量:44.29万
成交额:255.21万
市值:4.59亿
市盈率:-2.96
高:5.84
开:5.50
低:5.50
收:5.65
52周最高:6.45
52周最低:2.46
股本:7,967.21万
流通股本:5,950.97万
量比:1.21
换手率:0.74%
股息:- -
股息率:- -
每股收益(TTM):-1.9430
每股收益(LYR):-1.9430
净资产收益率:-44.34%
总资产收益率:-28.75%
市净率:1.67
市盈率(LYR):-2.96

数据加载中...

2024/02/07

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/07

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/28

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/09

重要事件披露

Form 8-K - Current report
2023/10/02

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/08/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/08

重要事件披露

Form 8-K - Current report
2023/06/22

重要事件披露

Form 8-K - Current report
2023/05/22

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2023/05/08

重要事件披露

8-K - Current report
2023/05/08

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/02/28

重要事件披露

8-K - Current report
2023/02/28

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]